Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients

被引:146
作者
Rowshani, AT
Bemelman, FJ
van Leeuwen, EMM
van Lier, RAW
ten Berge, IJM
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Clin Immunol & Rheumatol, NL-1100 DE Amsterdam, Netherlands
[2] Acad Med Ctr, Div Nephrol, Amsterdam, Netherlands
[3] Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands
关键词
cytomegalovirus; solid organ transplantation; immune response; renal transplantation; antiviral therapy;
D O I
10.1097/01.TP.0000148239.00384.F0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Primary cytomegalovirus (CMV) infection is a major cause of morbidity and mortality in recipients after solid organ transplantation (SOT). Widespread and prolonged use of antiviral drugs has changed the natural course of CMV disease by delaying its onset and causing drug resistance. CMV induces a strong cellular immune response, even in immunosuppressed patients, and has developed strategies to evade this immune surveillance. This review summarizes challenges in managing CMV infection in transplant recipients and highlights current insights in the cellular immune response against CMV.
引用
收藏
页码:381 / 386
页数:6
相关论文
共 75 条
[21]   PREEMPTIVE GANCICLOVIR THERAPY TO PREVENT CYTOMEGALOVIRUS DISEASE IN CYTOMEGALOVIRUS ANTIBODY-POSITIVE RENAL-TRANSPLANT RECIPIENTS - A RANDOMIZED CONTROLLED TRIAL [J].
HIBBERD, PL ;
TOLKOFFRUBIN, NE ;
CONTI, D ;
STUART, F ;
THISTLETHWAITE, JR ;
NEYLAN, JF ;
SNYDMAN, DR ;
FREEMAN, R ;
LORBER, MI ;
RUBIN, RH .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (01) :18-26
[22]   SYMPTOMATIC CYTOMEGALOVIRUS DISEASE IN THE CYTOMEGALOVIRUS ANTIBODY SEROPOSITIVE RENAL-TRANSPLANT RECIPIENT TREATED WITH OKT3 [J].
HIBBERD, PL ;
TOLKOFFRUBIN, NE ;
COSIMI, AB ;
SCHOOLEY, RT ;
ISAACSON, D ;
DORAN, M ;
DELVECCHIO, A ;
DELMONICO, FL ;
AUCHINCLOSS, H ;
RUBIN, RH .
TRANSPLANTATION, 1992, 53 (01) :68-72
[23]   Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients [J].
Humar, A ;
Uknis, M ;
Carlone-Jambor, C ;
Gruessner, RW ;
Dunn, DL ;
Matas, A .
TRANSPLANTATION, 1999, 67 (01) :94-97
[24]   Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease [J].
Humar, A ;
Kumar, D ;
Gilbert, C ;
Boivin, G .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (04) :581-584
[25]   CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes [J].
Janssen, EM ;
Lemmens, EE ;
Wolfe, T ;
Christen, U ;
von Herrath, MG ;
Schoenberger, SP .
NATURE, 2003, 421 (6925) :852-856
[26]   A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection [J].
Jenkins, C ;
Abendroth, A ;
Slobedman, B .
JOURNAL OF VIROLOGY, 2004, 78 (03) :1440-1447
[27]   Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells [J].
Kaech, SM ;
Tan, JT ;
Wherry, EJ ;
Konieczny, BT ;
Surh, CD ;
Ahmed, R .
NATURE IMMUNOLOGY, 2003, 4 (12) :1191-1198
[28]   Target structures of the CD8+-T-cell response to human cytomegalovirus:: the 72-kilodalton major immediate-early protein revisited [J].
Kern, F ;
Surel, IP ;
Faulhaber, N ;
Frömmel, C ;
Schneider-Mergener, J ;
Schönemann, C ;
Reinke, P ;
Volk, HD .
JOURNAL OF VIROLOGY, 1999, 73 (10) :8179-8184
[29]   Rat cytomegalovirus infection in kidney allograft recipients is associated with increased expression of intracellular adhesion molecule-1, vascular adhesion molecule-1, and their ligands leukocyte function antigen-1 and very late antigen-4 in the graft [J].
Kloover, JS ;
Soots, AP ;
Krogerus, LA ;
Kauppinen, HO ;
Loginov, RJ ;
Holma, KL ;
Bruggeman, CA ;
Ahonen, PJ ;
Lautenschlager, IT .
TRANSPLANTATION, 2000, 69 (12) :2641-2647
[30]   THE ASSOCIATION OF THE INDUCTION OF VASCULAR CELL-ADHESION MOLECULE-1 WITH CYTOMEGALOVIRUS ANTIGENEMIA IN HUMAN HEART ALLOGRAFTS [J].
KOSKINEN, PK .
TRANSPLANTATION, 1993, 56 (05) :1103-1108